Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Results from second pivotal study of Rayaldee for secondary hyperparathyroidism

Sep. 26, 2014

Asfotase alfa shows benefit in phase II trials in pediatric patients with hypophosphatasia

Sep. 26, 2014

Viable mouse models of methylmalonic acidemia created

Sep. 25, 2014

Merck & Co. presents results for MK-0674 in ovariectomized cynomolgus monkeys

Sep. 25, 2014

Ajinomoto presents new MGAT2 inhibitors for obesity and dyslipidemia

Sep. 25, 2014

Once-weekly GH replacement therapy with MOD-4023 shows promise in pediatric patients

Sep. 23, 2014

biOasis Technologies supports new preclinical study of Transcend technology in MPS II

Sep. 23, 2014

AGI-12026, a novel potent and selective IDH2 R140Q inhibitor shows promise in vivo

Sep. 23, 2014

Preclinical and phase I results presented for LY-2452473

Sep. 23, 2014

Shionogi discloses novel AMPK activators for diabetes

Sep. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...